Skip to content
Desvenlafaxine
Khedezla, Pristiq (desvenlafaxine) is a small molecule pharmaceutical. Desvenlafaxine was first approved as Pristiq on 2008-02-29. It is used to treat major depressive disorder in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target sodium-dependent dopamine transporter.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
mental disordersD001523
Trade Name
FDA
EMA
Pristiq (generic drugs available since 2015-06-29, discontinued: Khedezla)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Desvenlafaxine
Tradename
Company
Number
Date
Products
DESVENLAFAXINEAlembic PharmaceuticalsN-204150 RX2013-03-04
2 products, RLD, RS
Show 1 discontinued
Desvenlafaxine fumarate
Tradename
Company
Number
Date
Products
DESVENLAFAXINEsparcN-205583 DISCN2014-01-28
2 products, RLD
DESVENLAFAXINETevaN-205208 DISCN2013-10-11
2 products
Hide discontinued
Desvenlafaxine succinate
Tradename
Company
Number
Date
Products
PRISTIQCV SciencesN-021992 RX2008-02-29
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
desvenlafaxineANDA2023-05-03
pristiq New Drug Application2022-03-25
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
major depressive disorderEFO_0003761D003865F22
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Desvenlafaxine Succinate, Pristiq, Pf Prism Cv
82690402027-07-05DP
ATC Codes
N: Nervous system drugs
N06: Psychoanaleptics
N06A: Antidepressants
N06AX: Other antidepressants in atc
N06AX23: Desvenlafaxine
HCPCS
No data
Clinical
Clinical Trials
69 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Major depressive disorderD003865EFO_0003761F2262197437
DepressionD003863F33.915219
Hot flashesD01958423117
PharmacokineticsD01059922
Dysthymic disorderD019263EFO_0008623F34.1112
Breast neoplasmsD001943EFO_0003869C5011
Opioid-related disordersD009293EFO_0005611F1111
AnhedoniaD059445R45.8411
Anxiety disordersD001008EFO_0006788F41.111
Social phobiaD000072861EFO_1001917F40.111
Show 1 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients314
FibromyalgiaD005356EFO_0005687M79.11213
Depressive disorderD003866EFO_1002014F32.A33
Diabetic neuropathiesD003929EFO_1000783112
Cardiovascular diseasesD002318EFO_0000319I98111
NeoplasmsD009369C80111
MenopauseD008593EFO_0003922N9511
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bipolar disorderD001714EFO_0000289F30.911
Acute kidney injuryD058186HP_0001919N1711
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDESVENLAFAXINE
INNdesvenlafaxine
Description
O-desmethylvenlafaxine is a tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-hydroxyphenyl group. It is a metabolite of the drug venlafaxine. It has a role as a marine xenobiotic metabolite, a drug metabolite and an antidepressant. It is a member of cyclohexanols, a member of phenols and a tertiary amino compound.
Classification
Small molecule
Drug classantianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1
Identifiers
PDB
CAS-ID93413-62-8
RxCUI
ChEMBL IDCHEMBL1118
ChEBI ID83527
PubChem CID125017
DrugBankDB06700
UNII IDNG99554ANW (ChemIDplus, GSRS)
Target
Agency Approved
SLC6A2
SLC6A2
SLC6A4
SLC6A4
Organism
Homo sapiens
Gene name
SLC6A2
Gene synonyms
NAT1, NET1, SLC6A5
NCBI Gene ID
Protein name
sodium-dependent noradrenaline transporter
Protein synonyms
NET, neurotransmitter transporter, Norepinephrine transporter, solute carrier family 6 (neurotransmitter transporter), member 2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, Solute carrier family 6 member 2, solute carrier family 6 member 5
Uniprot ID
Mouse ortholog
Slc6a2 (20538)
sodium-dependent noradrenaline transporter (Q6QU62)
Alternate
SLC6A3
SLC6A3
Organism
Homo sapiens
Gene name
SLC6A3
Gene synonyms
DAT1
NCBI Gene ID
Protein name
sodium-dependent dopamine transporter
Protein synonyms
DA transporter, dopamine transporter 1, solute carrier family 6 (neurotransmitter transporter), member 3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, Solute carrier family 6 member 3
Uniprot ID
Mouse ortholog
Slc6a3 (13162)
sodium-dependent dopamine transporter (Q9R1I2)
Variants
Clinical Variant
No data
Financial
Pristiq - Pfizer
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,544 documents
View more details
Safety
Black-box Warning
Black-box warning for: Desvenlafaxine, Pristiq
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
113,308 adverse events reported
View more details